[ESPR] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
04-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -11.15%
YoY- -27.20%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 145,419 0 0 0 0 0 0 -
PBT 87,379 -46,130 -40,541 -14,585 -11,466 -7,874 -4,239 -
Tax 0 0 482 457 227 16 803 -
NP 87,379 -46,130 -40,541 -14,585 -11,466 -7,874 -4,239 -
Tax Rate 0.00% - - - - - - -
Total Cost 58,040 46,130 40,541 14,585 11,466 7,874 4,239 54.64%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 60.09 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 3.26 -1.73 -1.80 -0.65 -0.56 -0.51 -0.29 -
EPS Diluted 3.07 -1.73 -1.80 -0.65 -0.56 -0.51 -0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.